Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer

Cancer(2020)10.1002/cncr.32914Source: DataRank Database

Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer is a research paper published in Cancer (2020). On theSindex it has a DataRank of 2.1. It has been cited 44 times, with 39 citing works in its 1-hop citation network.

N/A

2.1DataRank · unranked

Scored on demand from live citation data

Open Access44 citations · 39 citing works in its network

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.41)OA: greenTopics (63)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 28%Citation Network 72%

Base Score Contribution

0.571

From this paper's citation signal

Citation Network Contribution

1.5

From 28 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 39 citers.

Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
Cancer Imaging202136 citations17 referencesContributes 0.212
Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
Current Oncology202110 citations14 referencesContributes 0.171
Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer
Cancer20205 citations11 referencesContributes 0.163
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma
European Urology202256 citations34 referencesContributes 0.119
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Clinical Cancer Research202188 citations43 referencesContributes 0.104

Authors (6)

Shantao Li ORCID,Harvey A. Risch ORCID,Ranjit S. Bindra ORCID,Patrick D. McGillivray ORCID,Mark Gerstein ORCID

Live enrichment

PubMed:32413184 OpenAlex:https://openalex.org/W3024547843

National Institutes of Health

Grant: 1K08CA207845‐01

National Institutes of Health

Grant: R01 HG008126

National Institutes of Health

Grant: UM1 HG006504

NCI NIH HHS

Grant: R01 CA215453

NCI NIH HHS

Grant: K08 CA207845

NIH HHS

Grant: 1K08CA207845-01

FWCI

2.41

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10316675/pdf/nihms-1903527.pdf

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.32914

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32914

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.32914

Fields of Study

Renal cell carcinoma treatmentRenal and related cancersMechanisms of cancer metastasisAdultExomeFemaleFumarate HydrataseGene FrequencyGenetic Predisposition to DiseaseGerm-Line MutationHeterozygoteHumansKidneyKidney NeoplasmsLeiomyomatosisMaleMiddle AgedNeoplastic Syndromes, HereditaryRisk FactorsSkin NeoplasmsUterine NeoplasmsHereditary leiomyomatosis and renal cell cancer

MeSH Terms

AdultFemaleFumarate HydrataseGene FrequencyHeterozygoteHumansKidneyKidney NeoplasmsMaleMiddle AgedNeoplastic Syndromes, HereditaryRisk FactorsSkin NeoplasmsUterine NeoplasmsGerm-Line MutationLeiomyomatosisGenetic Predisposition to DiseaseExome

Keywords

PenetranceKidney cancerCancerMedicineGermline mutationCancer syndromePopulationExomeExome sequencingAllele frequencyGeneticsOncologyAlleleInternal medicineCancer researchMutationBiologyGenePhenotypefumarate hydratase (FH)hereditaryhereditary leiomyomatosis and renal cancer (HLRCC)renal cell carcinoma

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.25092536.v1figshare

Additional file 1 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.25092536figshare

Additional file 3 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.26673354figshare

Additional file 3 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.26673354.v1figshare

Additional file 2 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.25092566figshare

Additional file 2 of Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

10.6084/m9.figshare.25092566.v1figshare